E-Z-EM’s wholly owned subsidiary AngioDynamics has filed a registration statement with the Securities and Exchange Commission (SEC) for an initial public offering (IPO) of common stock.
RBC Capital Markets will act as lead manager and sole book-running manager, with Adams Harkness and Hill serving as co-manager, according to Queensbury, NY-based AngioDynamics. The company’s application is for a listing on the Nasdaq National Market under the symbol “ANGO.”
By AuntMinnie.com staff writers
March 8, 2004
E-Z-EM continues strong growth in 2004 Q2, January 9, 2004
E-Z-EM, SourceOne to study barium cost reduction, August 28, 2003
E-Z-EM notches record 2003, August 13, 2003
E-Z-EM, Berlex to partner, July 15, 2003
E-Z-EM to close New York and Puerto Rico operations, June 2, 2003
Copyright © 2004 AuntMinnie.com
